Spectracef: Oral tablet (200mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Cornerstone Biopharma, a subsidiary of Chiesi USA
Cornerstone Biopharma, a subsidiary of Chiesi USA
TAP Pharmaceuticals Inc, a Takeda Company
Methapharm Inc
Methapharm Inc
What is this Medicine?
CEFDITOREN (sef DIT or in) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.
Spectracef 200mg Tablet
NDC: 101220801-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Pneumonia, Tonsillitis, Skin And Skin Structure Infections, Pharyngitis, Bronchitis, Community-acquired Pneumonia
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Reported Side Effects for Spectracef 200mg Tablet
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Compatible - This drug is generally safe to take by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


